Physician profile
Rani Das
NPI 1235165788
$17,008.95
in general payments reported to CMS, 2019-2025
71 companies · $2,791 in 2025
The $2,791 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,652 · 2020: $1,692 · 2021: $3,135 · 2022: $2,604 · 2023: $2,624 · 2024: $2,510 · 2025: $2,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,690 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,690.41 |
| Education | $234.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,366.82 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Abbvie INC. | $1,358.09 | 2021-2025 | Ubrelvy, Qulipta |
| Jazz Pharmaceuticals INC. | $863.88 | 2019-2025 | |
| Pfizer INC. | $830.11 | 2023-2025 | |
| Amgen INC. | $813.45 | 2019-2025 | Tavneos, Aimovig |
| Lilly USA, LLC | $767.75 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Sk Life Science, INC. | $713.56 | 2020-2025 | Xcopri |
| Ucb, INC. | $522.74 | 2019-2024 | Briviact |
| Biohaven Pharmaceutical Holding Company Ltd. | $520.27 | 2022 | |
| Harmony Biosciences LLC | $516.61 | 2020-2025 | |
| Corium, LLC | $509.58 | 2022-2025 | Azstarys, Adlarity |
| Novartis Pharmaceuticals Corporation | $508.50 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $457.77 | 2020-2021 | |
| Emd Serono, INC. | $451.78 | 2019-2024 | Mavenclad |
| Supernus Pharmaceuticals, INC. | $384.78 | 2019-2025 | Qelbree, Qelbree |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rani Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.